California and Colorado Society of CPAs hosted a national business symposium focused on cannabis.
In a virtual UCLA panel this week, a rep from the IRS laid out how the tax agency is aiming to work with the cannabis industry.
Critics want to slow down and get the plan right, and some worry that Covid may render projections too rosy.
The coronavirus slowed the push for cannabis industry access to banking, but the conversation might be more relevant now than ever.
A Cannabis Wire analysis shows that a handful of ancillary cannabis companies did, too.
One of the oldest names in cannabis, Harborside has been battling a federal tax bill for years, and the outcome could shape the industry’s future.
Some employees worry about their health as well as their jobs.
Cannabis Wire spoke with Jaci Flug, former general counsel for the New York State Liquor Authority, about her new role at alcohol delivery platform Drizly and its cannabis arm Lantern, and Lantern’s president.
US cannabis consumers and patients are asking questions like: will my local shop close? Will delivery be an option? Cannabis Wire is tracking cannabis regulators’ announcements.
On Wednesday, the Canadian company, one of the highest-valued cannabis companies in the world, announced its third round of layoffs since last month.
CEO David Klein said the moves aim “to lower our cost structure and reduce our cash burn.”
Amid the COVID-19 pandemic, a dilemma has hit the nascent industry: to close or not to close? We’re keeping track of how companies, and regulators, are reacting.
Consumer Brands Association—think Kellogg's, Pepsi, etc.—has created a high-voltage advisory board to frame its advocacy approach.
A complicated but lucrative industry draws eager investors and lots of lawyers, brokers, and advisers to serve them. Most are honest. But not all.
Crapo laid out “significant concerns” about the SAFE Banking Act on Wednesday, suggesting a 2% THC cap on products eligible for financial services.
Here’s what we found from the last two years: Hundreds of complaints, ranging from false data about THC content to obscenely positioned gummies.